当前位置:
X-MOL 学术
›
J. Clin. Periodontol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
The efficacy of reconstructive therapy in the surgical management of peri‐implantitis: A 3‐year follow‐up of a randomized clinical trial
Journal of Clinical Periodontology ( IF 5.8 ) Pub Date : 2024-07-18 , DOI: 10.1111/jcpe.14049 Stefan Renvert 1, 2, 3 , Jean-Louis Giovannoli 4 , Sven Rinke 5, 6
Journal of Clinical Periodontology ( IF 5.8 ) Pub Date : 2024-07-18 , DOI: 10.1111/jcpe.14049 Stefan Renvert 1, 2, 3 , Jean-Louis Giovannoli 4 , Sven Rinke 5, 6
Affiliation
AimTo assess whether guided bone regeneration (GBR) treatment of peri‐implantitis‐related bony defects could improve healing compared to open flap debridement (OFD) at 36 months.Materials and MethodsIn a multi‐centre, randomized clinical trial, 32 individuals received OFD (control group [CG]) and 34 GBR treatment (test group [TG]). Radiographic defect fill (RDF), probing pocket depth (PPD), bleeding on probing (BOP) suppuration (SUP), mucosal recession (MREC) and patient‐reported outcomes (PROs) were evaluated at 36 months.ResultsFifty individuals attended a supportive peri‐implant therapy program and completed the 36‐month follow‐up. GBR treatment resulted in an RDF of 2.13 ± 1.26 mm compared to 1.64 ± 1.54 mm following OFD (p = .18). No difference was found in PPD, BOP, SUP, REC or PROs between the groups. Successful treatment (no additional bone loss, PPD ≤ 5 mm, no BOP and no SUP) was achieved in 46.2% in TG and 20% in CG (p = .053). Treatment results obtained at 12 months were generally maintained up to 36 months. No significant changes were noticed between 12 and 36 months.ConclusionsAt 36 months, treatment results obtained at 1 year were sustained following both GBR and OFD in patients attending supportive peri‐implant therapy. GBR resulted in more RDF and higher composite treatment success rate than OFD (ClinicalTrials.gov Identifier [NCT02375750]).
中文翻译:
重建治疗在种植体周围炎手术治疗中的疗效:一项随机临床试验的 3 年随访
目的 评估与开放皮瓣清创术 (OFD) 相比,种植体周围相关骨缺损的引导骨再生 (GBR) 治疗是否可以改善 36 个月时的愈合。材料和方法在一项多中心、随机临床试验中,32 例接受了 OFD(对照组 [CG])和 34 例 GBR 治疗(试验组 [TG])。在 36 个月时评估影像学缺损填充 (RDF) 、探诊袋深度 (PPD)、探诊出血 (BOP) 化脓 (SUP)、粘膜萎缩 (MREC) 和患者报告结果 (PROs)。结果50 人参加了支持性种植体周围治疗计划并完成了 36 个月的随访。GBR 处理导致 RDF 为 2.13 ± 1.26 mm,而 OFD 后为 1.64 ± 1.54 mm (p = .18)。组间 PPD 、 BOP 、 SUP 、 REC 或 PRO 无差异。TG 为 46.2%,CG 为 20% (p = .053),成功治疗 (无额外的骨质流失,PPD ≤ 5 mm,无 BOP 和无 SUP) 。12 个月时获得的治疗结果通常可维持至 36 个月。在 12 至 36 个月之间未观察到显著变化。结论在 36 个月时,接受支持性种植体周围治疗的患者在 GBR 和 OFD 后获得的 1 年治疗结果均持续。GBR 导致比 OFD (ClinicalTrials.gov 标识符 [NCT02375750]) 更多的 RDF 和更高的复合处理成功率。
更新日期:2024-07-18
中文翻译:
重建治疗在种植体周围炎手术治疗中的疗效:一项随机临床试验的 3 年随访
目的 评估与开放皮瓣清创术 (OFD) 相比,种植体周围相关骨缺损的引导骨再生 (GBR) 治疗是否可以改善 36 个月时的愈合。材料和方法在一项多中心、随机临床试验中,32 例接受了 OFD(对照组 [CG])和 34 例 GBR 治疗(试验组 [TG])。在 36 个月时评估影像学缺损填充 (RDF) 、探诊袋深度 (PPD)、探诊出血 (BOP) 化脓 (SUP)、粘膜萎缩 (MREC) 和患者报告结果 (PROs)。结果50 人参加了支持性种植体周围治疗计划并完成了 36 个月的随访。GBR 处理导致 RDF 为 2.13 ± 1.26 mm,而 OFD 后为 1.64 ± 1.54 mm (p = .18)。组间 PPD 、 BOP 、 SUP 、 REC 或 PRO 无差异。TG 为 46.2%,CG 为 20% (p = .053),成功治疗 (无额外的骨质流失,PPD ≤ 5 mm,无 BOP 和无 SUP) 。12 个月时获得的治疗结果通常可维持至 36 个月。在 12 至 36 个月之间未观察到显著变化。结论在 36 个月时,接受支持性种植体周围治疗的患者在 GBR 和 OFD 后获得的 1 年治疗结果均持续。GBR 导致比 OFD (ClinicalTrials.gov 标识符 [NCT02375750]) 更多的 RDF 和更高的复合处理成功率。